Hi there,

Our generous triple match has been extended, which means your donation to Democracy Now! today will be TRIPLED. If you give $10, we'll get $30 to support our independent journalism. Please don’t miss out on this opportunity to triple your impact. Democracy Now! is a free source of independent news for tens of millions of people around the world, but less than 1% of our global audience donates to support our critical reporting. Let’s pick up the percentage! We rely on you for support—not the oil, gas, coal and nuclear companies when we cover the climate crisis or the weapons manufacturers when we cover war. I hope you’ll give as much as you can today. Every dollar makes a difference. Thanks so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Standing up to Big Pharma in Bangladesh: Right Livelihood Laureate Dr. Zafrullah Chowdhury

Web ExclusiveApril 19, 2011
Media Options

Democracy Now! talks to Dr. Zafrullah Chowdhury, co-founder of Bangladeshi charity Gonoshasthaya Kendra (GK, The People’s Health Center) which provides education, job opportunities and low-cost, locally-produced essential drugs to rural Bangladeshis. GK received the Right Livelihood Award in 1992.

Dr. Chowdhury was a key force behind the Bangladesh National Drug Policy in 1982, which restricted the number of imported drugs and encouraged locally-manufactured versions at drastically reduced prices.

Related Story

StoryNov 18, 2022Exiled Russian Environmentalist: Russia’s Uranium Sales to U.S. & Europe Help Putin Fund Ukraine War
The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top